glycine/tyrosine

SEQUENCE LISTING A computer readable form copy of the Sequence Listing entitled "P482D_SeqList.txt" is herein incorporated by reference. This Sequence Listing consists of [SEQ. ID NOs:1-5]. BACKGROUND OF THE INVENTION The present invention relates to a blood-viscosity reducing agent which reduces

BACKGROUND OF THE INVENTION Laminin (Mr=900,000) is a large glycoprotein specific to basement membranes. Laminin has been shown to promote cell adhesion, cell growth, cell migration, neurite outgrowth, cell differentiation, and to influence the metastatic behavior of tumor cells. Laminin binds to

BACKGROUND OF INVENTION Radiation therapy, a common treatment for malignancies, can cause severe damage to the lung--a highly radiosensitive organ. Radiation can cause a broad spectrum of pneumopathies, including acute-phase alveolitis/pneumonitis, late-stage chronic pulmonary fibrosis, and various

BACKGROUND OF THE INVENTION The present invention relates to sweet proteins. Specifically, this invention relates to Brazzein protein that has been modified to provide a candy-like taste with high potency. The most widely used natural sweetener, sugar (sucrose), has significant problems associated

BACKGROUND OF THE INVENTION The present invention relates to sweet proteins. Specifically, this invention relates to Brazzein protein that has been modified to provide a candy-like taste with high potency. The most widely used natural sweetener, sugar (sucrose), has significant problems associated

BACKGROUND OF THE INVENTION The present invention relates to a novel peptide, a process of preparing the same, pharmaceutical compositions comprising the same, and its use as pharmaceuticals, anti-inflammatory and anti-sarcoma agents. The peptide is particularly useful as pharmaceuticals for

TECHNICAL FIELD This invention relates to a novel polypeptide and a method for preparing the same, more particularly to a novel polypeptide exhibiting strong affinity for lipopolysaccharide (endotoxin) and a method for preparing the same. BACKGROUND ART Endotoxin is also called an intracellular

TECHNICAL FIELD This invention relates to a novel polypeptide and a method for preparing the same, more particularly to a novel polypeptide exhibiting strong affinity for lipopolysaccharide (endotoxin) and a method for preparing the same. BACKGROUND ART Endotoxin is also called an intracellular

BACKGROUND OF THE INVENTION The present invention relates to an amino acid-trehalose composition developed on the basis of the knowledge obtained from a study of a composition which comprises amino acids contained in the saliva secreted by the larvae of a hornet (belonging to the genus Vespa) and

BACKGROUND OF THE INVENTION This invention relates to a nutritional composition and more particularly to a nutritional composition for the management of protein intake. Protein intake, especially in human beings, has received the considerable attention of researchers, nutritionists, medical

The present invention relates to the use of certain amino acid copolymers as moisturizers and to the cosmetic compositions in which said amino acid copolymers are present. In the description of the present invention and in the claims which follow, the abbreviations used for the amino acids are those

The present invention is directed towards mixtures comprising (A) 90 to 99.9% by weight of a mixture of L- and D-enantiomers of methyl glycine diacetic acid (MGDA) or its respective mono-, di- or trialkali metal or mono-, di- or triammonium salts, said mixture containing predominantly the respective

FIELD OF THE INVENTION This invention relates to reagents and a method for determining the activity of herpesvirus proteases. More particularly, the invention relates to fluorogenic substrates and a fluorometric assay for CMV protease and other herpesvirus proteases. BACKGROUND OF THE

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a National Stage application of PCT/JP2012/069869, filed Aug. 3, 2012, which claims priority from Japanese Application No. 2011-171507, filed Aug. 5, 2011. TECHNICAL FIELD The present invention relates to a method for detecting a novel

The present invention relates to the field of medical approaches for ocular diseases that may lead to partial or total blindness. The invention provides useful tools to be applied topically into the eyes, including peptides and analogs of these peptides. BACKGROUND ART Retinal neurodegenerative